Toggle Main Menu Toggle Search

Open Access padlockePrints

Microsatellite scanning of the immunogenome associates MAPK14 and ELTD1 with graft-versus-host disease in hematopoietic stem cell transplantation

Lookup NU author(s): Dr Christian Harkensee, Dr Peter Middleton, Professor Andrew GenneryORCiD


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Graft-versus-host disease (GVHD) is the main complication after hematopoietic stem cell transplantation (HSCT). Evidence for non-HLA gene polymorphisms as a cause of GVHD lacks consistency, which is, in part, due to methodological issues of previous candidate gene association studies and small effect size of their results, demanding for larger scale and more robust approaches. Here, non-HLA gene polymorphisms were studied on a large population (922 HSCT pairs) from a homogeneous ethnic background with selection/correction for important clinical confounders. A methodology was applied exploiting the strength of confirmatory typing in an independent study cohort. Targeting an immunogenome of 2,909 genes, an approach of pooled DNA typing of 4,321 microsatellite (MS) markers in two independent screening steps and confirmation of associated markers by further individual genotyping on combined screening cohorts was used to identify genetic susceptibility loci for moderate to severe GVHD (grades 2-4). Ten MS loci (D5S424, D6S0035i, D1S0818i, DXS0151i, D17S0219i, DXS0629i, DXS0324i, D17S0271i, D6S0330i, and D1S1335i) passed the two pooled DNA typing steps and confirmation by individual sample genotyping; two of these (D1S0818i-ELTD1 and D6S0035i-MAPK14) remain associated following application of Bonferroni's correction and multivariate analysis. The MAPK14 locus was exemplarily explored by typing of haplotype single nucleotide polymorphisms (SNP) confirming this association. This study identified several new MS susceptibility loci for GVHD that warrant further investigation. Immunogenome scanning using MS markers is a useful method for the identification of non-HLA gene loci associating with HSCT outcomes.

Publication metadata

Author(s): Harkensee C, Oka A, Onizuka M, Middleton PG, Inoko H, Nakaoka H, Gennery AR, Ando K, Morishima Y, Japan Marrow Donor Programme

Publication type: Article

Publication status: Published

Journal: Immunogenetics

Year: 2013

Volume: 65

Issue: 6

Pages: 417-427

Print publication date: 01/06/2013

Online publication date: 09/03/2013

Acceptance date: 16/02/2013

ISSN (print): 0093-7711

ISSN (electronic): 1432-1211

Publisher: Springer


DOI: 10.1007/s00251-013-0691-z


Altmetrics provided by Altmetric


Funder referenceFunder name
Daiwa Foundation
297Kay Kendall Leukaemia Fund UK (KKLF)
291Kay Kendall Leukaemia Fund UK (KKLF)
3224-22133011Ministry of Education, Culture, Sports, Science and Technology, Japan through JMDP
H23-010Ministry of Health, Labor, and Welfare of Japan
H20-014Ministry of Health, Labor, and Welfare of Japan